A Study to Test the Safety and Effectiveness of an Investigational Vaccine in Infants (V419-002)

NCT00551629 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

708

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Infections; Virus Diseases

Interventions

BIOLOGICAL: AR51 (12, 10)
BIOLOGICAL: PR51 (3, 10)
BIOLOGICAL: PR51 (6, 10)
BIOLOGICAL: PR51 (6, 15)

Sponsor

Merck Sharp & Dohme LLC